Lv71
4715 积分 2020-09-11 加入
Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a)
2小时前
已完结
Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels
2小时前
已完结
Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a)
3小时前
已完结
Lipoprotein(a) and Cardiovascular Disease in Chinese Population
6天前
已完结
Buntanetap, a Novel Translational Inhibitor of Multiple Neurotoxic Proteins, Proves to Be Safe and Promising in Both Alzheimer's and Parkinson's Patients
2个月前
已完结
A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with early Alzheimer’s Disease
2个月前
已完结
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation
3个月前
已完结
Synaptogenic effect of APP -Swedish mutation in familial Alzheimer’s disease
3个月前
已完结
Hormone Receptor-Positive / HER2-Negative Early Breast Cancer High-Risk Population: An Algorithm for Optimization Systemic Adjuvant Treatment Based on 2022 Updates
3个月前
已关闭
皖公网安备34019202002308
